Strand Life Sciences' liquid biopsy test to help early detection of cancer

The Bengaluru-based Strand Life Sciences’ new liquid biopsy (LB) test portfolio, Strand LB, will provide highly sensitive detection of tumour traces from a simple blood draw. This tool, launched last week, can provide early and precise indication of tumour presence, cancer recurrence, and response to therapy compared to any other method used in the medical industry.

According to Indian Council of Medical Research (ICMR), India is projected to have 17.3 lakhs new cases of cancer reported in 2020 and over 8.8 lakhs patients are expected to die from the disease. To counter this large burden and rapid increase in incidence and